The active ingredient in Victoza, liraglutide, does exist as another brand-name product called Saxenda. Saxenda, in comparison to Victoza, is approved by the FDA as a weight loss drug. However ...

Apart from Victoza, which was approved for Type 2 diabetes in 2010, liraglutide also underpins Novo’s older weight loss drug Saxenda and its insulin-degludec-based diabetes combination therapy ...

Novo Nordisk (NVO) markets liraglutide under the brand names Victoza, Saxenda and Xultophy. The drug is currently on the FDA's drug shortage list. Compounding pharmacies are allowed to make ...

The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight management, Biocon Ltd said in a regulatory filing. Victoza and Saxenda are ...

Biocon Ltd and its European partner, Zentiva, have received a decentralised procedure approval in the European Union for their complex formulation, Liraglutide used in the treatment of diabetes and ...